[en] ("[en] BACKGROUND: Identifying people with HIV (PWH) at risk for chronic kidney disease, cardiovascular events, and death is crucial. We evaluated biomarkers to predict all-cause mortality and cardiovascular events, and measured glomerular filtration rate (mGFR) slope.
METHODS: Biomarkers were measured at enrollment. Baseline and 5-year mGFR were measured by plasma iohexol clearance. Outcomes were a composite criterion of all-cause mortality and/or cardiovascular events, and mGFR slope.
RESULTS: Of 168 subjects, 146 (87.4%) had undetectable HIV load. Median follow-up was 59.1 months (interquartile range, 56.2-62.1). At baseline, mean age was 49.5 years (± 9.8) and mean mGFR 98.9 mL/min/1.73m2 (± 20.6). Seventeen deaths and 10 cardiovascular events occurred during 5-year follow-up. Baseline mGFR was not associated with mortality/cardiovascular events. In multivariable analysis, cystatin C (hazard ratio [HR], 5.978; 95% confidence interval [CI], 2.774-12.88; P < .0001) and urine albumin to creatinine ratio (uACR) at inclusion (HR, 1.002; 95% CI, 1.001-1.004; P < .001) were associated with mortality/cardiovascular events. Area under receiver operating curve of cystatin C was 0.67 (95% CI, .55-.79) for mortality/cardiovascular event prediction. Biomarkers were not associated with GFR slope.
CONCLUSIONS: uACR and cystatin C predict all-cause mortality and/or cardiovascular events in PWH independently of mGFR.","[en] ","")
Disciplines :
Laboratory medicine & medical technology Immunology & infectious disease Urology & nephrology
Author, co-author :
Chazot, Robin; Department of Nephrology, Dialysis and Transplantation, University Hospital of Saint-Etienne, Saint-Etienne, France
Botelho-Nevers, Elisabeth ; Department of Infectious and Tropical Diseases, University Hospital of Saint-Etienne, Saint-Etienne, France ; Groupe Immunité des Muqueuses et Agents Pathogènes, University of Jean Monnet and Université de Lyon, Saint-Etienne, France
Mariat, Christophe; Department of Nephrology, Dialysis and Transplantation, University Hospital of Saint-Etienne, Saint-Etienne, France ; Groupe Immunité des Muqueuses et Agents Pathogènes, University of Jean Monnet and Université de Lyon, Saint-Etienne, France
Frésard, Anne; Department of Infectious and Tropical Diseases, University Hospital of Saint-Etienne, Saint-Etienne, France
Cavalier, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Lucht, Frédéric; Department of Infectious and Tropical Diseases, University Hospital of Saint-Etienne, Saint-Etienne, France ; Groupe Immunité des Muqueuses et Agents Pathogènes, University of Jean Monnet and Université de Lyon, Saint-Etienne, France
Delanaye, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service de néphrologie
Maillard, Nicolas; Department of Nephrology, Dialysis and Transplantation, University Hospital of Saint-Etienne, Saint-Etienne, France ; Groupe Immunité des Muqueuses et Agents Pathogènes, University of Jean Monnet and Université de Lyon, Saint-Etienne, France
Gagneux-Brunon, Amandine ; Department of Infectious and Tropical Diseases, University Hospital of Saint-Etienne, Saint-Etienne, France ; Groupe Immunité des Muqueuses et Agents Pathogènes, University of Jean Monnet and Université de Lyon, Saint-Etienne, France
Language :
English
Title :
Cystatin C and Urine Albumin to Creatinine Ratio Predict 5-Year Mortality and Cardiovascular Events in People Living With HIV.
Smit M, Brinkman K, Geerlings S, et al; ATHENA Observational Cohort. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 2015; 15:810-8.
Schouten J, Wit FW, Stolte IG, et al; AGEhIV Cohort Study Group. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014; 59:1787-97.
Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol 2009; 5:591-8.
Chazot R, Botelho-Nevers E, Frésard A, et al. Diagnostic challenges of kidney diseases in HIV-infected patients. Expert Rev Anti Infect Ther 2017; 15:903-15.
Campos P, Ortiz A, Soto K. HIV and kidney diseases: 35 years of history and consequences. Clin Kidney J 2016; 9:772-81.
Berliner AR, Fine DM, Lucas GM, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 2008; 28:478-86.
Mallipattu SK, Salem F, Wyatt CM. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int 2014; 86:259-65.
Mocroft A, Ryom L, Begovac J, et al; EuroSIDA in EuroCOORD. Deteriorating renal function and clinical outcomes in HIV-positive persons. AIDS 2014; 28:727-37.
Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. The impact of HIV on chronic kidney disease outcomes. Kidney Int 2007; 72:1380-7.
Scherzer R, Lin H, Abraham A, et al. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women. Nephrol Dial Transplant 2016; 31:1478-85.
Choi A, Scherzer R, Bacchetti P, et al. Cystatin C, albumi-nuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010; 56:872-82.
Peralta C, Scherzer R, Grunfeld C, et al. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS). HIV Med 2014; 15:291-300.
Inker LA, Wyatt C, Creamer R, et al. Performance of creat-inine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr 2012; 61:302-9.
Gagneux-Brunon A, Delanaye P, Maillard N, et al. Performance of creatinine and cystatin C-based glomer-ular filtration rate estimating equations in a European HIV-positive cohort. AIDS 2013; 27:1573-81.
Ronco C, Rizo-Topete L, Serrano-Soto M, Kashani K. Pro: prevention of acute kidney injury: time for teamwork and new biomarkers. Nephrol Dial Transplant 2017; 32:408-13.
Johnson ACM, Zager RA. Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. J Am Soc Nephrol 2018; 29:2157-67.
Cavalier E, Rozet E, Dubois N, et al. Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clin Chim Acta 2008; 396:80-5.
Bröchner-Mortensen J, Haahr J, Christoffersen J. A simple method for accurate assessment of the glomerular filtration rate in children. Scand J Clin Lab Invest 1974; 33:140-3.
Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-71.
Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and al-buminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121:651-8.
Wyatt CM, Hoover DR, Shi Q, et al. Pre-existing albumi-nuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 2011; 16:591-6.
Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant 2011; 26:3224-9.
Schutte R, Schmieder RE, Huisman H W, et al. Urinary albumin excretion from spot urine samples predict all-cause and stroke mortality in Africans. Am J Hypertens 2014; 27:811-8.
Hadigan C, Edwards E, Rosenberg A, et al. Microalbuminuria in HIV disease. Am J Nephrol 2013; 37:443-51.
Lescure FX, Fellahi S, Pialoux G, et al. Prevalence of tubulopathy and association with renal function loss in HIV-infected patients. Nephrol Dial Transplant 2020; 35:607-15.
Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352:2049-60.
Gagneux-Brunon A, Mariat C, Delanaye P. Cystatin C in HIV-infected patients: promising but not yet ready for prime time. Nephrol Dial Transplant 2012; 27:1305-13.
Gupta SK, Kitch D, Tierney C, Melbourne K, Ha B, McComsey GA; AIDS Clinical Trials Group Study A5224s Team. Markers of renal disease and function are associated with systemic inflammation in HIV infection. HIV Med 2015; 16:591-8.
Kruzel-Davila E, Wasser WG, Aviram S, Skorecki K. APOL1 nephropathy: from gene to mechanisms of kidney injury. Nephrol Dial Transplant 2016; 31:349-58.
Melsom T, Nair V, Schei J, et al. Correlation between baseline GFR and subsequent change in GFR in Norwegian adults without diabetes and in Pima Indians. Am J Kidney Dis 2019; 73:777-85.
Lucas GM, Atta MG, Zook K, et al. Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals. AIDS 2016; 30:619-26.
Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311:2518-31.
Ascher SB, Scherzer R, Estrella MM, et al. Associations of urine biomarkers with kidney function decline in HIV-infected and uninfected men. Am J Nephrol 2019; 50:401-10.
Pelchen-Matthews A, Ryom L, Borges ÁH, et al; EuroSIDA study. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS 2018; 32:2405-16.
Petersen N, Knudsen AD, Mocroft A, et al. Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study. HIV Med 2019; 20:639-47.
